Screenshot_2.jpg
Blue Star Foods Announces 1-for-50 Reverse Stock Split
15 mai 2024 12h00 HE | Blue Star Foods Corp.
Miami, FL, May 15, 2024 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (ESG)...
RM Primary Logo - Humble.png
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
08 mai 2024 16h02 HE | Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Cardiff.jpg
Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
02 mai 2024 16h05 HE | Cardiff Oncology, Inc.
- In RAS-mutated mCRC, clinical data from ONSEMBLE trial, and preclinical data presented at AACR, demonstrated strong efficacy signal in bev naïve patients and support ongoing first-line RAS-mutated...
RM Primary Logo - Humble.png
Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024
01 mai 2024 16h05 HE | Revolution Medicines, Inc.
REDWOOD CITY, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Screenshot_2.jpg
Blue Star Foods Secures Additional Non-Dilutive Growth Capital to Support Expansion of Business Under Existing Master Service Agreement & Soft Shell Crab Operations
17 avr. 2024 11h00 HE | Blue Star Foods Corp.
Miami, FL, April 17, 2024 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,” “our” or “us”) (NASDAQ: BSFC), an integrated Environmental, Social, and Governance (ESG)...
Screenshot_2.jpg
Blue Star Foods Signs Agreement with Eagle Rising to Provide High-Quality, Nutritious Meals for U.S. Military
10 avr. 2024 11h00 HE | Blue Star Foods Corp.
Initial Launch Expected to Roll Out to Numerous Military Bases Over the Next Few Months Miami, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Blue Star Foods Corp., (“Blue Star,” the “Company,” “we,”...
RM Primary Logo - Humble.png
Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
09 avr. 2024 15h34 HE | Revolution Medicines, Inc.
REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Immuneering-logo (1).png
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
09 avr. 2024 12h00 HE | Immuneering Corporation
IMM-1-104 is Synergistic with Chemotherapy in Pancreatic Cancer Models
RM Primary Logo - Humble.png
Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
08 avr. 2024 11h36 HE | Revolution Medicines, Inc.
Two original papers in Nature highlight the discovery and translational implications of RMC-7977, a RAS(ON) multi-selective tri-complex inhibitor that exhibits unprecedented anti-tumor activity in...
RM Primary Logo - Humble.png
Revolution Medicines to Participate in Upcoming Investor Conferences
04 avr. 2024 16h05 HE | Revolution Medicines, Inc.
REDWOOD CITY, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...